Exact Sciences Corp (EXAS)

Apr 24, 2025

Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance

Apr 24, 2025

Apr 24, 2025

Exact Sciences (EXAS): Among Billionaire George Soros’ Small-Cap Stocks with Huge Upside Potential - Insider Monkey

Apr 24, 2025

Apr 23, 2025

Billionaire George Soros’ 10 Small-Cap Stocks with Huge Upside Potential - Insider Monkey

Apr 23, 2025

Apr 23, 2025

Liquid Biopsy in Cancer Diagnostics Market to Grow at a CAGR of ~17% by 2032 with Advancements in Non-Invasive Testing | DelveInsight - GlobeNewswire Inc.

Apr 23, 2025

Apr 22, 2025

EXAS Quantitative Stock AnalysisBenjamin Graham - Nasdaq

Apr 22, 2025

Apr 22, 2025

Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic By Stocktwits - Investing.com India

Apr 22, 2025

Apr 22, 2025

Exact Sciences Launches New Test To Monitor Cancer Recurrence: Retail’s Optimistic - MSN

Apr 22, 2025

Apr 22, 2025

Exact Sciences launches the Oncodetect MRD test - TipRanks

Apr 22, 2025

Apr 22, 2025

Exact Sciences (EXAS) Launches Oncodetect Test for Enhanced Cancer Care | EXAS Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test | EXAS Stock News - GuruFocus

Apr 22, 2025

Apr 22, 2025

Exact Sciences Launches the Oncodetect™ Molecular Residual Disease Test - Business Wire

Apr 22, 2025

Apr 18, 2025

Market Sentiment Around Loss-Making Exact Sciences Corporation (NASDAQ:EXAS) - simplywall.st

Apr 18, 2025

Apr 15, 2025

Immuno-Oncology Stocks Q4 In Review: Exact Sciences (NASDAQ:EXAS) Vs Peers - Yahoo Finance

Apr 15, 2025

Apr 14, 2025

Exact Sciences (EXAS) Validates Oncotype DX Test for Diverse Bre - GuruFocus

Apr 14, 2025

Apr 14, 2025

JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups - The Joplin Globe

Apr 14, 2025

Apr 10, 2025

Deep Dive Into Exact Sciences Stock: Analyst Perspectives (8 Ratings) - Benzinga

Apr 10, 2025

Apr 10, 2025

Mizuho Initiates Exact Sciences at Outperform With $60 Price Target - marketscreener.com

Apr 10, 2025

Apr 09, 2025

Mizuho sets $60 target on Exact Sciences stock, sees outperform - Investing.com

Apr 09, 2025

Apr 09, 2025

Mizuho sets $60 target on Exact Sciences stock, sees outperform By Investing.com - Investing.com UK

Apr 09, 2025

Apr 08, 2025

Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - GlobeNewswire Inc.

Apr 08, 2025

Apr 02, 2025

10 Promising Biotech Stocks to Invest in (April 2025) - Securities.io

Apr 02, 2025

Apr 01, 2025

Exact Sciences Schedules First Quarter 2025 Earnings Call - The Joplin Globe

Apr 01, 2025

Mar 31, 2025

Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening - BioSpace

Mar 31, 2025

Mar 31, 2025

Revolutionary Cancer Test Achieves 95% Accuracy, Cuts Unnecessary Procedures by 40% - Stock Titan

Mar 31, 2025

Mar 28, 2025

Benchmark maintains Buy on Exact Sciences, price target at $65 By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Benchmark maintains Buy on Exact Sciences, price target at $65 - Investing.com

Mar 28, 2025

Mar 28, 2025

Exact Sciences Positioned for Growth with Upcoming Product Launches and Margin Expansion - TipRanks

Mar 28, 2025

Mar 28, 2025

High Growth Tech Stocks To Watch In The US March 2025 - Yahoo Finance

Mar 28, 2025

Mar 27, 2025

Should You Retain Exact Sciences Stock in Your Portfolio Now? - Yahoo Finance

Mar 27, 2025

Mar 24, 2025

Why Exact Sciences Corporation (EXAS) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025

Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025

Mar 21, 2025

Exact Sciences (EXAS) Down 10.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

Should You Invest in Exact Sciences Corp. (EXAS)? - MSN

Mar 21, 2025

Mar 19, 2025

SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN - Quantisnow

Mar 19, 2025

Mar 19, 2025

Former Exact Sciences COO Joins Sera Prognostics Board Amid Strategic Expansion - Stock Titan

Mar 19, 2025

Mar 18, 2025

"Pick Up Your Poop" F Cancer's New Campaign Encourages At-Home Colorectal Cancer Screening - WV News

Mar 18, 2025

Mar 17, 2025

RBC Capital Initiates Coverage of Exact Sciences (BMV:EXAS) with Sector Perform Recommendation - Nasdaq

Mar 17, 2025

Mar 13, 2025

Commit To Buy EXACT Sciences At $30, Earn 14% Using Options - Nasdaq

Mar 13, 2025

Mar 13, 2025

Expert Outlook: Exact Sciences Through The Eyes Of 7 Analysts - Benzinga

Mar 13, 2025

Mar 13, 2025

PreventionGenetics Assumes the Management of Sponsored Genetic Testing Program for Three Rare Genetic Diseases: Acute Hepatic Porphyria, Primary Hyperoxaluria Type 1 & Hereditary ATTR Amyloidosis - Business Wire

Mar 13, 2025

Mar 12, 2025

Exact Sciences initiated with a Sector Perform at RBC Capital - TipRanks

Mar 12, 2025

Mar 12, 2025

Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner - Joplin Globe

Mar 12, 2025

Mar 12, 2025

Exact Sciences Triples Industry Average in Employee Engagement, Wins Prestigious Gallup Award - StockTitan

Mar 12, 2025

Mar 12, 2025

New Data Highlight the Positive Impact of Exact Sciences’ Oncotype DX - Business Wire

Mar 12, 2025

Mar 11, 2025

Charles Schwab Investment Management Inc. Grows Holdings in Exact Sciences Co. (NASDAQ:EXAS) - Defense World

Mar 11, 2025

Mar 11, 2025

Exact Sciences Co. (NASDAQ:EXAS) Stake Increased by Jones Financial Companies Lllp - Defense World

Mar 11, 2025

Mar 07, 2025

3 Top Cancer Biotechs to Keep An Eye On in 2025 - Yahoo Finance

Mar 07, 2025

Mar 06, 2025

Exact Sciences at Raymond James Conference: Strategic Growth and Innovation - Investing.com

Mar 06, 2025

Mar 05, 2025

La Paloma CC: Set to host PGA Tour Champions' Cologuard Classic - The First Call

Mar 05, 2025

Mar 04, 2025

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS) - Yahoo Finance

Mar 04, 2025